159 related articles for article (PubMed ID: 21924695)
21. Resection of cancer of the body and tail of the pancreas.
Burcharth F; Trillingsgaard J; Olsen SD; Moesgaard F; Federspiel B; Struckmann JR
Hepatogastroenterology; 2003; 50(50):563-6. PubMed ID: 12749273
[TBL] [Abstract][Full Text] [Related]
22. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
23. Resectable pancreatic cancer: who really benefits from resection?
Barugola G; Partelli S; Marcucci S; Sartori N; Capelli P; Bassi C; Pederzoli P; Falconi M
Ann Surg Oncol; 2009 Dec; 16(12):3316-22. PubMed ID: 19707831
[TBL] [Abstract][Full Text] [Related]
24. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
25. Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.
Van den Broeck A; Sergeant G; Ectors N; Van Steenbergen W; Aerts R; Topal B
Eur J Surg Oncol; 2009 Jun; 35(6):600-4. PubMed ID: 19131205
[TBL] [Abstract][Full Text] [Related]
26. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
[TBL] [Abstract][Full Text] [Related]
27. Surgery for mucin-producing pancreatic tumor.
Yasuda H; Takada T; Amano H; Yoshida M
Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855
[TBL] [Abstract][Full Text] [Related]
28. Actual long-term outcome of T1 and T2 pancreatic ductal adenocarcinoma after surgical resection.
Han SH; Heo JS; Choi SH; Choi DW; Han IW; Han S; You YH
Int J Surg; 2017 Apr; 40():68-72. PubMed ID: 28232032
[TBL] [Abstract][Full Text] [Related]
29. Assessment of pathologic response after preoperative chemoradiotherapy and surgery in pancreatic adenocarcinoma.
Moutardier V; Magnin V; Turrini O; Viret F; Hennekinne-Mucci S; Gonçalves A; Pesenti C; Guiramand J; Lelong B; Giovannini M; Monges G; Houvenaeghel G; Delpero JR
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):437-43. PubMed ID: 15380577
[TBL] [Abstract][Full Text] [Related]
30. Carcinoma of the pancreas: resection outcome at the University Hospital Kuala Lumpur.
Shahrudin MD
Int Surg; 1997; 82(3):269-74. PubMed ID: 9372373
[TBL] [Abstract][Full Text] [Related]
31. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials.
Butturini G; Stocken DD; Wente MN; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Dervenis C; Bassi C; Büchler MW; Neoptolemos JP;
Arch Surg; 2008 Jan; 143(1):75-83; discussion 83. PubMed ID: 18209156
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival after surgical resection for pancreatic cancer.
Yoshizawa K; Nagai H; Kurihara K; Sata N; Kawai T; Saito K
Hepatogastroenterology; 2001; 48(40):1153-6. PubMed ID: 11490822
[TBL] [Abstract][Full Text] [Related]
33. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
Shimada K; Sakamoto Y; Sano T; Kosuge T
Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
[TBL] [Abstract][Full Text] [Related]
34. [Is resection of left-sided ductal pancreatic carcinoma of value?]].
Gebhardt C; Meyer W; Jurowich C
Zentralbl Chir; 2000; 125(12):966-9. PubMed ID: 11190614
[TBL] [Abstract][Full Text] [Related]
35. Surgery insight: surgical management of pancreatic cancer.
Michalski CW; Weitz J; Büchler MW
Nat Clin Pract Oncol; 2007 Sep; 4(9):526-35. PubMed ID: 17728711
[TBL] [Abstract][Full Text] [Related]
36. [Surgical resection of pancreatic adenocarcinoma: indications and contraindications, pronostic factors and survival, recent advances].
Delpero JR
Cancer Radiother; 2004 Nov; 8 Suppl 1():S73-9. PubMed ID: 15679251
[TBL] [Abstract][Full Text] [Related]
37. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
38. Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas.
Nagai S; Fujii T; Kodera Y; Kanda M; Sahin TT; Kanzaki A; Yamada S; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakao A
Pancreas; 2011 Jan; 40(1):3-9. PubMed ID: 20881897
[TBL] [Abstract][Full Text] [Related]
39. A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?
Kooby DA; Hawkins WG; Schmidt CM; Weber SM; Bentrem DJ; Gillespie TW; Sellers JB; Merchant NB; Scoggins CR; Martin RC; Kim HJ; Ahmad S; Cho CS; Parikh AA; Chu CK; Hamilton NA; Doyle CJ; Pinchot S; Hayman A; McClaine R; Nakeeb A; Staley CA; McMasters KM; Lillemoe KD
J Am Coll Surg; 2010 May; 210(5):779-85, 786-7. PubMed ID: 20421049
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
